Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374231 · ClinicalTrials.gov registry record · Phase 4
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00374231 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 40 participants.
The verdict
NCT00374231, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
To determine the safety and efficacy of early corticosteroid discontinuation in liver transplant recipients more than 90 days post transplant, utilizing a combination of two drugs (tacrolimus and mycophenolate mofetil) for maintenance immunosuppressant therapy.
Interventions
- DRUG Prednisone
- DRUG tacrolimus
- DRUG mycophenolate mofetil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374231
The ClinicalTrials.gov registry entry for NCT00374231 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prednisone is the first listed.
NCT00374231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374231 about?
NCT00374231 is a clinical study titled "Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients". To determine the safety and efficacy of early corticosteroid discontinuation in liver transplant recipients more than 90 days post transplant, utilizing a combination of two drugs (tacrolimus and mycophenolate mofetil) for maintenance immunosuppressant therapy.
What is the current status of trial NCT00374231?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2002-10. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00374231?
The interventions under investigation include: Prednisone (DRUG), tacrolimus (DRUG), mycophenolate mofetil (DRUG).
Who is sponsoring clinical trial NCT00374231?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.